Related by context. Frequent words. (Click for all words.) 85 Initiates Phase II 79 Initiates Phase 79 Completes Enrollment 78 Initiate Phase 77 Commences Phase 77 Presents Positive 77 Drug Candidate 75 Patient Enrollment 74 Phase III Trial 74 Pivotal Phase 74 FDA Accepts 73 Pivotal Phase III 73 Phase III Clinical Trial 73 Clinical Trial Results 72 Announces Initiation 72 Preclinical Data 71 Metastatic Melanoma 71 Pivotal Study 71 Develop Novel 70 FDA Clears 70 Significantly Improves 70 Announces Presentation 70 Announces Publication 70 Single Dose 69 Pivotal Trial 69 Inc Therapeutic Competitors 69 Announces FDA Clearance 69 Receives FDA Clearance 69 Significantly Reduces 68 Files Shelf Registration Statement 68 refractory chronic lymphocytic 68 II Clinical Trial 68 Announces Successful Completion 68 Shows Promise 68 Pulmonary Arterial Hypertension 67 Receives Positive 67 Panzem R 67 Cholesterol Drug 67 Small Molecule 67 Chronic Hepatitis C 67 Exploit collaboration 67 Generic Version 67 Monoclonal Antibody 67 MKC# 67 Aliskiren 67 Transcept Pharmaceuticals 67 Study Demonstrates 66 Reports Positive 66 Secures Financing 66 RNAi Therapeutics 66 Recombinant Human 66 THERAPEUTICS 66 Significantly Increases 66 Daclizumab 65 KRN# 65 Announces Positive 65 Patients Treated 65 PHARM 65 Q2 Loss Narrows 65 please visit http:/www.supergen.com 65 Patent Covering 65 ThermoDox R 65 Regains Compliance 65 Combination Therapy 65 Heart Failure Patients 65 Regains Compliance With 65 R sorafenib tablets 65 Renal Cell Carcinoma 65 Phase Ib clinical 65 Announces Issuance 65 Voreloxin 65 Achieves Milestone 65 Metastatic Colorectal Cancer 64 Monotherapy 64 Inhibits 64 gets USFDA nod 64 Updates Status 64 Inc. Nasdaq IMGN 64 Issues Guidance 64 DVAX 64 Idera Pharmaceuticals 64 Q1 Loss Narrows 64 Chronic Heart Failure 64 Receives Patent 64 Reduces Risk 64 Myelofibrosis 64 Epratuzumab 64 Low Dose 64 FDA Approves 64 Kuvan R 64 Drug Resistant 64 Completes Financing 64 CHEAP ONLINE PHARMACY LOW 64 targeting CD# 64 Positive Opinion 64 CRTX 64 Phase Ib II 64 Gastric Cancer 64 Completes Tender Offer 64 Stockholders Approve Merger 64 Cetrorelix